StockGlow

Iterum Therapeutics plc (ITRMF)

Develops oral antibiotics to treat drug-resistant bacterial infections.

$0.03+0.00%Healthcare
Compare ITRMF with
StockGlow Score
4
Bearish
BearishBullish
1 year ago-95.8%

The outlook

ITRMF is trading near its 52-week lows at $0.031, well below both its 50- and 200-day moving averages. The stock sits just 3% above its annual floor, signaling a sustained downtrend. Current analyst coverage appears minimal or unavailable for this microcap name.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Market cap
$1.7M
52-wk high
$0.91
52-wk low
$0.01
50-day avg
$0.04
200-day avg
$0.25
Trailing P/E
—

Similar stocks

VISLVislink Technologies, Inc.$2.79+7.72%CTRMCastor Maritime Inc.$1.89+1.61%ARTLArtelo Biosciences, Inc.$0.88-12.86%JAGXJaguar Health, Inc.$0.96-3.55%FAMIFarmmi, Inc.$0.15-1.56%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy